Clin2
NCT07567040Possibly a fitRecruiting

Delaying Nearsightedness Onset in Children

Myopia

Part of Eyes & vision clinical trials.

This study tests whether low-dose atropine eye drops can prevent or slow down nearsightedness in children ages 6–11 who don't yet need glasses. The goal is to keep children's vision stable and reduce their need for corrective lenses as they grow.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
664 people
Ages
6 years to 11 years
Study type
Interventional

Who can take part

  • Child is between 6 and 11 years old with vision that is normal or very slightly blurry (not yet nearsighted)
  • Child has no significant differences in eye focus between the two eyes
  • Child has no eye diseases, previous eye surgery, or eye alignment problems (crossed eyes)
  • Child is willing and able to use artificial tear drops at least 90% of the time during a 2–4 week test period
  • Child has no serious health conditions that affect eye focusing (like diabetes, multiple sclerosis, or Down syndrome)
  • Child has never been treated with atropine drops or special contact lenses to control nearsightedness

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07095894Recruiting· Phase 3
Glasses or eye drops for slowing nearsightedness in kids

This study tests whether special glasses or low-dose atropine eye drops can slow down worsening nearsightedness in children. It compares four groups: glasses alone, eye drops alone, both together, or a placebo (no active treatment).

Birmingham, Alabama
NCT06708156Recruiting· Phase 3
Low-dose atropine drops to slow childhood nearsightedness

This trial tests two low-dose atropine eye drops (0.01% and 0.02%) to see if they can safely slow down the worsening of nearsightedness (myopia) in children. Your child would receive either one of these drops or a placebo (an inactive drop) once daily for up to 2 years.

Hefei, Anhui
NCT06389110Recruiting· Phase 3
Low-dose atropine drops to slow children's nearsightedness

This study tests whether a very low-dose atropine eye drop (0.01%) can safely slow down worsening nearsightedness in children. It is for kids ages 3 to 12 who are already nearsighted but haven't used other myopia control treatments before.

Mexico City
NCT07863713Not yet recruiting· Phase 2
Early treatment plan for children at risk of nearsightedness

This study tests an early intervention for 5-6 year old children who are at risk of developing nearsightedness (myopia). The goal is to see if starting treatment early can prevent or slow down vision problems, which might help your child avoid stronger glasses later.

NCT07164092Not yet recruiting· Phase 2/Phase 3
Atropine eye drops to slow myopia in children

This trial tests whether atropine eye drops can reduce the progression of myopia (nearsightedness, where you have trouble seeing far away) in children. It might help slow down the worsening of vision over time.

NCT06034379Recruiting
Special glasses vs. eye drops for nearsighted kids

This study compares two ways to slow down worsening nearsightedness in children: special electronic glasses versus low-dose atropine eye drops. It may help your child keep their eyesight from getting much worse over time.

Hsinchu

Hear when a new Myopia trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.